MaaT Pharma joins Microbiome Therapeutics Innovation Group

MaaT Pharma, a clinical-stage biotech company focused on the development of Microbiome Ecosystem Therapies (MET) dedicated to improving survival outcomes for patients with cancer, is now a member of Microbiome Therapeutics Innovation Group (MTIG).

Related Keywords

Nikole Kimes ,Microbiome Therapeutics Innovation Group ,Rebiotix Inc ,Ferring Company ,Microba Life Sciences ,Maat Pharma ,Siolta Therapeutics ,Genetic Analysis ,Seres Therapeutics ,Servatus Biopharmaceuticals ,Markets Amp Regulations ,Emerging Markets ,Icrobiome ,Dancer ,Ncology ,Atient Centricity ,